Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Which potent opioid? Important criteria for selection.

J G Bovill

    Drugs
    |May 1, 1987
    PubMed
    Summary

    Newer opioids offer safer and more tailored pain management options. Potent agonists are used in hospitals, while agonist-antagonists provide safer chronic pain relief with fewer side effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Nikolay Ivanovich Pirogov (1810-1881): Anatomical research to develop surgery.

    Clinical anatomy (New York, N.Y.)·2019
    Same author

    Nikolay Ivanovich Pirogov: a surgeon's contribution to military and civilian anaesthesia.

    Anaesthesia·2014
    Same author

    Inhalation anaesthesia: from diethyl ether to xenon.

    Handbook of experimental pharmacology·2008
    Same author

    Drugs and haemostasis.

    Current opinion in anaesthesiology·2006
    Same author

    Mechanisms of anaesthesia: time to say farewell to the Meyer-Overton rule.

    Current opinion in anaesthesiology·2006
    Same author

    Intravenous anesthesia for the patient with left ventricular dysfunction.

    Seminars in cardiothoracic and vascular anesthesia·2006

    Area of Science:

    • Pharmacology
    • Anesthesiology
    • Pain Management

    Background:

    • Opioids are primary treatments for severe pain.
    • Recent advancements have introduced potent new opioid analgesics.
    • These newer agents offer improved safety and tailored therapeutic profiles compared to older compounds.

    Purpose of the Study:

    • To review the classification and clinical applications of modern opioid analgesics.
    • To highlight the pharmacological and pharmacokinetic differences enabling patient-specific treatment selection.
    • To discuss the advantages of newer opioids in various clinical settings, including anesthesia and chronic pain management.

    Main Methods:

    • Classification of opioids based on receptor activity (mu-agonists, agonist-antagonists).
    • Review of clinical uses, potency, and pharmacokinetic profiles of specific agents like fentanyl, alfentanil, sufentanil, butorphanol, nalbuphine, and buprenorphine.
    • Comparison of newer opioids with older agents regarding efficacy, safety, and side effect profiles.

    Main Results:

    • Potent mu-agonists (e.g., fentanyl derivatives) are effective for anesthesia but require hospital use due to respiratory depression risk.
    • Newer fentanyl derivatives (alfentanil, sufentanil) offer advantages in potency, duration, and recovery time.
    • Agonist-antagonists (butorphanol, nalbuphine, buprenorphine) provide effective pain relief with a ceiling effect on respiratory depression and lower dependence risk, suitable for chronic pain and myocardial infarction.
    • Buprenorphine demonstrates prolonged action and versatile administration routes.

    Conclusions:

    • Modern opioids are classified by receptor activity, guiding clinical selection.
    • Newer potent opioids and agonist-antagonists provide safer, more effective pain management strategies.
    • Tailored use of these agents optimizes patient outcomes in diverse clinical scenarios, from surgery to chronic pain.

    Related Experiment Videos